Supernus Pharmaceuticals Allow for Loan/Lease Loss (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

53.87 -0.40 (-0.74%) USD | NASDAQ | Mar 06, 16:00

53.92 +0.05 (+0.09%) After-Hours: 20:00

View Allow for Loan/Lease Loss (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Allow for Loan/Lease Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Allow for Loan/Lease Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Allow for Loan/Lease Loss (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	--
BridgeBio Pharma, Inc.	--
Corcept Therapeutics, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Cytokinetics, Inc.	--